GFAP and Alexander disease: Furthermore, the expression levels of GFAP appear to modulate the pathogenesis of ALXDRD, likely acting on the penetrance and expressivity of the variants11 and opening new perspectives on the down-regulation of GFAP gene expression as a therapeutic target12.